Magnesium L-threonate for perimenopause sleep: the evidence

Magnesium L-threonate for perimenopause sleep is a promising idea with very little evidence behind it. No trial has been done in perimenopausal women, the one placebo-controlled sleep trial lasted 21 days in 80 adults and found no overall difference in insomnia scores, and each dose holds little magnesium. It is not proven better than glycinate.

What magnesium L-threonate is

Magnesium L-threonate is magnesium bound to L-threonate, a small organic molecule. It was developed by researchers who wanted a form of magnesium that would raise magnesium inside the brain. Their reasoning, set out in a 2016 trial report, is that in people even large rises in blood magnesium change the magnesium level in the fluid around the brain only slightly. They reported that the threonate form could raise that fluid’s magnesium when taken by mouth, based on their animal work.

The best-known study is in rats. In 2010, researchers reported that magnesium L-threonate raised brain magnesium in rats and improved learning, working memory and short- and long-term memory, along with changes in the connections between nerve cells in the hippocampus. That is interesting biology, but rat memory studies do not tell us what happens to a woman’s sleep at 3 a.m.

What the human trials show

Only a few human trials exist, and none was done in women in the menopause transition.

Study	Who	What they took	Result
Hausenblas 2024	80 adults aged 35 to 55 with self-reported sleep problems	1 g a day of magnesium L-threonate (about 75 mg elemental magnesium) or placebo, 2 hours before bed, for 21 days	Insomnia scores improved in both groups, with no significant difference overall; sleep-tracker deep and REM sleep scores and some daytime ratings favored threonate
Liu 2016	44 adults aged 50 to 70 with cognitive impairment	1.5 to 2 g a day of a magnesium L-threonate product or placebo for 12 weeks	Overall cognitive scores improved more than with placebo; effects on sleep could not be determined because of strong placebo effects

The sleep trial in detail

The 2024 trial is the main reason threonate is marketed for sleep. Participants answered sleep questionnaires each week and wore a sleep-tracking ring. On the Insomnia Severity Index, the main insomnia questionnaire, average scores fell from about 12 to about 8 in the threonate group and from about 13 to about 9 with placebo. The difference between groups over the whole study was not statistically significant, although the threonate group kept improving after the first week while the placebo group leveled off.

The positive findings were mostly from the ring: deep sleep and REM sleep scores, activity and “readiness” scores. Consumer sleep trackers estimate sleep stages rather than measuring them the way a sleep lab does, so these results are less reliable than they sound. On questionnaires, the threonate group did better on some items, such as how they felt on waking, energy, mood and alertness.

Three more cautions apply. The trial lasted only three weeks. Results were analyzed for 38 people per group. And it was funded by an ingredient company, which also employed three of the six authors. That does not make the results wrong, but it is a reason to wait for independent trials.

The cognition trial

The 2016 trial was designed to test memory and thinking in older adults. Overall cognitive scores improved more on the threonate product than on placebo. Sleep quality was also measured, but placebo effects were so strong that the authors said the effect on sleep could not be determined. The study was funded by the developer, which also analyzed the cognitive data and wrote the paper.

Why there is no perimenopause trial, and what that means

No study has looked at threonate, or any magnesium form, for sleep in perimenopausal women. That matters because sleep in the transition is often broken by night sweats, anxiety, falling progesterone or sleep apnea, and magnesium does not target any of those. If a hot flash wakes you, magnesium will not stop it. Our guide to why perimenopause wakes you at 3 a.m. goes through the usual causes, and our overview of magnesium for perimenopause sleep covers what the wider magnesium trials show.

How much magnesium you actually get

The amount of elemental magnesium, the mineral itself, is the main practical difference between threonate and other forms. In the 2024 trial, each gram of magnesium L-threonate supplied about 75 mg of elemental magnesium. That means:

• the 1 g a day used in the sleep trial gave about 75 mg of magnesium
• 1.5 to 2 g a day, the range used in the cognition trial, would give roughly 110 to 150 mg at the same magnesium content

For comparison, the recommended dietary allowance for women aged 31 and older is 320 mg a day from all sources, and the bisglycinate sleep trial used 250 mg of elemental magnesium a day. If you are taking magnesium because your diet is low in it, threonate is a slow way to fill the gap. Labels often list the weight of the compound in large print; see how to read a supplement label to find the elemental amount.

Cost

Because each capsule carries little magnesium, you usually need several capsules a day to reach trial doses, and threonate products often cost more than common forms such as glycinate or citrate. Compare the cost per daily dose, not per bottle, and remember that a higher price has not been shown to buy better sleep.

Threonate vs glycinate vs citrate

	Magnesium L-threonate	Magnesium glycinate (bisglycinate)	Magnesium citrate
Elemental magnesium per typical daily dose	About 75 to 150 mg	250 mg in the sleep trial	Varies by product
Human sleep trials	One 21-day trial in 80 adults; no overall difference in insomnia scores	One 4-week trial in 155 adults; small improvement in insomnia scores	None specific to citrate
Main selling point	Designed to reach the brain, based on animal data	Often chosen as gentler on the bowel	Well absorbed; draws water into the bowel
Tested in perimenopause	No	No	No

The bisglycinate trial found insomnia scores fell 3.9 points with magnesium versus 2.3 with placebo after 4 weeks, a small effect, with possibly more benefit in people who ate little magnesium. Across three trials in older adults, people on magnesium fell asleep about 17 minutes faster than on placebo, with low to very low certainty. Neither result is large, but both are based on more magnesium per dose than threonate provides. For the bowel and absorption differences between the two common forms, see magnesium citrate vs glycinate.

Safety and the 350 mg limit

The Institute of Medicine set the tolerable upper intake level for magnesium from supplements at 350 mg a day for adults. The limit applies to magnesium from non-food sources, such as supplements, antacids and laxatives, added together; magnesium in food does not count. It was chosen because diarrhea is the first sign of too much supplemental magnesium, and taking magnesium with food likely reduces that effect. Threonate at trial doses stays below the limit, but combining it with another magnesium product may not.

Talk to a clinician or pharmacist before starting if:

• you have kidney disease. The Institute of Medicine notes that dangerously high blood magnesium occurs mainly when impaired kidney function is combined with large intakes of non-food magnesium.
• you take antibiotics, bone medicines or diuretics. Magnesium can affect how some of these are absorbed or handled; our guide to magnesium for perimenopause sleep lists the main interactions and spacing advice.

In the trials, threonate was well tolerated. In the 12-week trial, digestive side effects affected 20.0% of people on the threonate product and 15.4% on placebo, not a significant difference. Long-term safety has not been studied.

A realistic plan

If you want to try it, use a single-ingredient product, start at the dose on the label, and give it 3 to 4 weeks. Start a sleep diary a week or two before you begin, so you can see whether anything changed. Choose a product with independent quality testing; third-party testing explained covers what the seals mean.

Keep expectations in proportion. Cognitive behavioral therapy for insomnia (CBT-I) is the treatment the American Academy of Sleep Medicine strongly recommends for chronic insomnia; see CBT-I for menopause insomnia. If night sweats wake you, treating them helps sleep more than any supplement.

When to see a clinician

Book a visit if poor sleep has lasted more than a few weeks and is affecting your days. Go sooner if you snore loudly or wake gasping, fall asleep during the day without meaning to, have night sweats most nights, or have low mood or anxiety that is hard to manage. A sleep medicine specialist can check for sleep apnea and arrange CBT-I. If you have thoughts of harming yourself, call or text 988. In an emergency, call 911.